AGC Biologics to Expand Biopharmaceutical CDMO Capacity ...Middle East

PR Newswire - News
AGC Biologics to Expand Biopharmaceutical CDMO Capacity
SEATTLE, Nov. 30, 2020 /PRNewswire/ -- AGC Biologics announced that it will increase the production capacity of its Copenhagen facility. AGC Biologics will construct a new building on land adjacent to its current Copenhagen site, adding production floors with 2000L single-use bioreactors,...

Read More Details
Finally We wish PressBee provided you with enough information of ( AGC Biologics to Expand Biopharmaceutical CDMO Capacity )

Also on site :